Discussing The Key Issues For Early And Late Stage Testing

Expert speaker insights from:

Developing successful stability testing strategies to avoid recalls, manage resources and implement cutting edge practices

The pressure to ensure that the regulatory requirements for stability testing are fulfilled, first time has never been higher with the pharmaceutical industry as a whole focusing on cutting margins and avoiding recalls. Those involved in stability testing have to maintain high standards whilst dealing with heavy budget and time constraints. Establishing an effective and efficient stability testing programme is key to ensuring regulations are upheld whilst staying within your margins

Pharma IQ’s Stability Testing Conference is an industry focused event, allowing you the opportunity to discuss with industry leaders and regulators, the key challenges your are currently facing in the area as well as how you can utilise the best procedures to deliver high quality data first time.

The unique dual stream approach, enables you to spend time focused on either early or late stage stability testing and combat the issues which directly affect you. Case studies from industry key players, as well as dedicated panel and round table sessions will allow enhanced interaction and exchange ideas as well as maximising alliance opportunities.

Key topics to be discussed:

Successfully adopting Quality by Design as part of your stability testing programme: the benefits and the challenges

Accelerated Stability Assessment Programmes: How to effectively to apply this to your current programmes in-house

Successfully outsourcing stability testing: How to successfully source and manage a 3rd party CRO

The developing regulatory landscape: Understanding how to ensure you fully comply with regulatory bodies to ensure first time approval

Ensuring you have a robust strategy in place for post release stability testing and variations
Transportation and packaging concerns in relation to extending shelf life and how oyu can use this to your advantage

Testimonials

Here is what attendees have said about previous conferences in the Pharma IQ series:

Very valuable, learned a lot, inspired.
Raquel Dias Miranda, Novartis Pharma AG
It was very valuable to have an overview about techniques which can be used and which basics are needed for this. It showed me that other pharmaceutical companies are faced with the same problems and to exchange on this
Susanne Tollar, Solvay Pharmaceuticals
I learned some interesting new technologies & approaches
Nuno Silva, Hovione Farmaciencia SA
Media Partners
_media

[ Register Now ]